Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,60116,620 of 20,252 grants

Completed SBIR-STTR RPGS
Ultra-sensitive Singlet Oxygen Dosimeter for Skin Cancer Treatment and Prevention
NATIONAL CANCER INSTITUTE Physical Sciences, Inc United States 2021 – 2023

Project Summary/Abstract Skin cancer is the most common form of cancer. Each year in the U.S. alone over 5.4 million cases of nonmelanoma skin cancer are treated. The annual cost o...

$9.26M
USD
Completed OTHER RESEARCH-RELATED
Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2022

Project Summary Given advances in screening and treatment, the number of people in the U.S. living with lung cancer is expected to increase by 25% (from 571,340 to 724,610) by 2030...

$1.25M
USD
Active NON-SBIR/STTR RPGS
Regulatory T cells in cancer therapy
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2026

Project Summary Extensive studies have been conducted to define the development, conversion, stability, and regulatory mechanisms of CD4+Foxp3+ regulatory T cells (Tregs) in homeos...

$6.34M
USD
Completed NON-SBIR/STTR RPGS
Statistical methods for cancer progression delineation and subtype identification
NATIONAL CANCER INSTITUTE University of Kentucky United States 2021 – 2024

Project Summary Carcinogenesis is a complex process involving somatic mutations in a number of key biological pathways and processes. Full study of the temporal order of somatic mu...

$749K
USD
Active OTHER RESEARCH-RELATED
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide. The development of targeted molecular therapies that inhibit m...

$2.09M
USD
Active OTHER RESEARCH-RELATED
Prognostic and Therapeutic Implications of IFNAR1 Signaling on CAR T Cell Therapy for Cancer
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2026

Adoptive cellular therapy (ACT) has revolutionized the treatment of certain malignancies and responses in refractory B cell tumors treated with chimeric antibody receptor (CAR)-exp...

$1.54M
USD
Active NON-SBIR/STTR RPGS
Twist1 as a Target for Prevention and Treatment of Cutaneous Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE University of Texas At Austin United States 2021 – 2026

PROJECT SUMMARY The overall goal of the proposed research is to understand the role of Twist1 in cutaneous squamous cell carcinoma (cSCC) and to develop novel approaches for target...

$3.55M
USD
Active NON-SBIR/STTR RPGS
Vascularized tumor explants for drug testing
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2026

Project Abstract Our understanding of cancer progression or response to therapies would benefit from easily accessible, patient- specific assays that recapitulate the biology and a...

$3.71M
USD
Active NON-SBIR/STTR RPGS
Rational in situ programming of cancer vaccine-responding T-cell clones
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2021 – 2026

Project Summary Currently no method exists that would allow physicians to rapidly and reliably establish T-cell immunity against tumor antigens. Bioinformatics tools can predict an...

$4.64M
USD
Active NON-SBIR/STTR RPGS
A Genetically Tractable Mouse Model for PRKCI-driven Lung Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE Mayo Clinic Jacksonville United States 2021 – 2026

Project Abstract Lung cancer is the number one cause of cancer death in the United States. Non-small cell lung cancer (NSCLC), which accounts for the majority (80%) of lung cancer...

$3.51M
USD
Active TRAINING, INDIVIDUAL
Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma
NATIONAL CANCER INSTITUTE University of Florida United States 2021 – 2026

Project Summary/Abstract Programmed cell death 1 (PD-1) and its ligands, PD-L1 and PD-L2, are highly expressed in human and murine thymus. Despite this knowledge, the function of t...

$417.5K
USD
Active NON-SBIR/STTR RPGS
Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen resistance
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

SUMMARY. Kinase inhibitors targeting the catalytic subunit of the DNA-dependent protein kinase (DNAPKcs) are being developed to sensitize tumors to clastogenic (chromosomal-breakin...

$3.95M
USD
Active NON-SBIR/STTR RPGS
Precision magnetic hyperthermia by integrating magnetic particle imaging
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Precision magnetic hyperthermia by integrating magnetic particle imaging Magnetic activation of magnetic iron oxide nanoparticles (MIONPs) offers considerable potential for numerou...

$6.15M
USD
Active NON-SBIR/STTR RPGS
Enhancing the efficacy of androgen signaling inhibitors in prostate cancer
NATIONAL CANCER INSTITUTE University of Kentucky United States 2021 – 2026

Title: Enhancing the efficacy of androgen signaling inhibitors in prostate cancer Abstract It has been documented that androgen receptor (AR) signaling remains to play a critical r...

$4.85M
USD
Active NON-SBIR/STTR RPGS
CONNECT: COmpreheNsive traiNing and Engagement in Cessation Treatment
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2027

PROJECT SUMMARY Adult smoking prevalence in the United States (US) is approximately 14% nationwide, yet significant disparities persist, including among adults with annual househol...

$5.95M
USD
Active NON-SBIR/STTR RPGS
Androgen receptor pathway inhibition through targeting PARP-2 in castration-resistant prostate cancer
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2021 – 2026

ABSTRACT Androgen receptor (AR) is ligand-activated transcription factor and a driver of prostate cancer (PCa). Understanding the molecular mechanisms of AR-mediated transcription...

$4.01M
USD
Active NON-SBIR/STTR RPGS
Targeting TET DNA Dioxygenases as Therapeutic Principle in Myeloid Neoplasms
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Ten Eleven Translocation (TET1, TET2 and TET3) are α-ketoglutarate (αKG) and Fe2+ dependent DNA- dioxygenases that is a key regulator of epigenetic landsca...

$5.96M
USD
Active NON-SBIR/STTR RPGS
Examining the Mechanisms Underlying the Influence of Facebook Food Advertisements on Adolescents' Eating Behaviors: Randomized Controlled Trials
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2026

Project Summary Poor diet and excess weight during adolescence predicts excess weight and diet-related cancers during adulthood, yet there is little research on the risk factors th...

$4.9M
USD
Completed NON-SBIR/STTR RPGS
Dynamic prediction incorporating time-varying covariates for the onset of breast cancer
NATIONAL CANCER INSTITUTE Washington University United States 2021 – 2025

PROJECT SUMMARY Accurate assessment of risk is a top priority in oncology due to the population burden of cancer. Breast cancer is the leading cancer diagnosis among women worldwid...

$3.74M
USD
Active NON-SBIR/STTR RPGS
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

Project Summary/Abstract Colorectal cancer (CRC) is the second leading cause of cancer mortality in the United States, and obesity, which affects 40% of the population, not only in...

$4.85M
USD